Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicago Inc MDCGF

Healthcare Biotechnology


GREY:MDCGF - Post by User

Medicago Inc > Desjardins puts MDG at buy
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(28)
•••
Comment by Indicatoron Jun 22, 2011 2:41pm
246 Views
Post# 18751574

RE: RE: Desjardins puts MDG at buy

RE: RE: Desjardins puts MDG at buywe've had the gamut here ... from $1.25 up to Paradigm's target:

February 17, 2011
"Paradigm Capital analyst Alan Ridgeway has assumed coverage of Medicago(TSX:MDG) with a “buy” rating and $2.50 price target."

Proof is in the pudding.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities